MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202541124404 A) filed by Saveetha Institute Of Medical And Technical Sciences, Chennai, Tamil Nadu, on Dec. 10, 2025, for 'development of nano particles based sensors for the detection of urea and creatine in ckd patients from the biological samples.'
Inventor(s) include Dr Mokila Deekshitha Reddy; Dr Ananthakumar P. K; Dr. Rajeshkumar S; and Deepak Nallaswamy Veeraiyan.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "The invention discloses a nanoparticle-based biosensor for non-invasive detection of urea and creatinine, key biomarkers of chronic kidney disease (CKD), from biological fluids .The biosensor comprises functionalized nanoparticles (e.g., gold nanoparticles, metal oxides, carbon nanostructures, quantum dots) modified with specific enzymes, aptamers, or molecularly imprinted polymers that selectively interact with urea and creatinine. The interaction generates optical or electrochemical signal changes enabling quantitative detection within clinically relevant concentration ranges. The system offers high sensitivity, selectivity, rapid response, and compatibility with portable or wearable devices, facilitating real-time point-of-care monitoring of CKD biomarkers."
Disclaimer: Curated by HT Syndication.
